Under Commure’s deal with Tenet, thousands of physicians could potentially use the AI scribe, according to a spokesperson. Commure didn’t detail a timeline when the tool could be fully rolled out.
Raymond James downgraded Tenet Healthcare (THC) to Outperform from Strong Buy with an unchanged price target of $195. The firm expects a reduction in the Affordable Care Act exchange population in ...
Dallas-based Tenet Healthcare, parent company of ASC chain United Surgical Partner International, will launch Commure's ambient AI platform across its physician network.
Results that may be inaccessible to you are currently showing.